Π£ Π½Π°Ρ Π²Ρ ΠΌΠΎΠΆΠ΅ΡΠ΅ ΠΏΠΎΡΠΌΠΎΡΡΠ΅ΡΡ Π±Π΅ΡΠΏΠ»Π°ΡΠ½ΠΎ Synthesis Workshop: Asymmetric Hydrogenation of Oximes with Dr. Josep Mas-RosellΓ³ (Episode 23) ΠΈΠ»ΠΈ ΡΠΊΠ°ΡΠ°ΡΡ Π² ΠΌΠ°ΠΊΡΠΈΠΌΠ°Π»ΡΠ½ΠΎΠΌ Π΄ΠΎΡΡΡΠΏΠ½ΠΎΠΌ ΠΊΠ°ΡΠ΅ΡΡΠ²Π΅, Π²ΠΈΠ΄Π΅ΠΎ ΠΊΠΎΡΠΎΡΠΎΠ΅ Π±ΡΠ»ΠΎ Π·Π°Π³ΡΡΠΆΠ΅Π½ΠΎ Π½Π° ΡΡΡΠ±. ΠΠ»Ρ Π·Π°Π³ΡΡΠ·ΠΊΠΈ Π²ΡΠ±Π΅ΡΠΈΡΠ΅ Π²Π°ΡΠΈΠ°Π½Ρ ΠΈΠ· ΡΠΎΡΠΌΡ Π½ΠΈΠΆΠ΅:
ΠΡΠ»ΠΈ ΠΊΠ½ΠΎΠΏΠΊΠΈ ΡΠΊΠ°ΡΠΈΠ²Π°Π½ΠΈΡ Π½Π΅
Π·Π°Π³ΡΡΠ·ΠΈΠ»ΠΈΡΡ
ΠΠΠΠΠΠ’Π ΠΠΠΠ‘Π¬ ΠΈΠ»ΠΈ ΠΎΠ±Π½ΠΎΠ²ΠΈΡΠ΅ ΡΡΡΠ°Π½ΠΈΡΡ
ΠΡΠ»ΠΈ Π²ΠΎΠ·Π½ΠΈΠΊΠ°ΡΡ ΠΏΡΠΎΠ±Π»Π΅ΠΌΡ ΡΠΎ ΡΠΊΠ°ΡΠΈΠ²Π°Π½ΠΈΠ΅ΠΌ Π²ΠΈΠ΄Π΅ΠΎ, ΠΏΠΎΠΆΠ°Π»ΡΠΉΡΡΠ° Π½Π°ΠΏΠΈΡΠΈΡΠ΅ Π² ΠΏΠΎΠ΄Π΄Π΅ΡΠΆΠΊΡ ΠΏΠΎ Π°Π΄ΡΠ΅ΡΡ Π²Π½ΠΈΠ·Ρ
ΡΡΡΠ°Π½ΠΈΡΡ.
Π‘ΠΏΠ°ΡΠΈΠ±ΠΎ Π·Π° ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠ΅ ΡΠ΅ΡΠ²ΠΈΡΠ° ClipSaver.ru
In this Research Spotlight episode, Dr. Josep Mas-RosellΓ³ joins us to talk about his recently published work on the asymmetric hydrogenation of oximes in the Cramer group. Parent reference: Science 2020, 368, 1098-1102. Other references (in order of appearance): βThe Chemistry of Hydroxylamines, Oximes and Hydroxamic Acidsβ John Wiley & Sons, Ltd. 2008; βThe Chemistry of Hydroxylamines, Oximes and Hydroxamic Acidsβ John Wiley & Sons, Ltd. 2008; βThe market of chiral drugsβ J. Pharmaceut. Biomed. 2018, 323; βAsymmetric homogeneous hydrogenations at scaleβ Chem. Soc. Rev. 2012, 3340. βTransition Metal-Catalyzed Enantioselective Hydrogenation of Enamines and Iminesβ Chem. Rev. 2011, 1713. βOuter sphere hydrogenation catalysisβ, O. Eisenstein, R. H. Crabtree, New J. Chem. 2013, 21. For a review on chiral cyclopentadienyl ligands (CpX) in catalysis, see: Angew. Chem. Int. Ed. 10.1002/anie.202008166. βEnantioselective oxime hydrogenation processβ T. Smejkal, N. Cramer, J. Mas-RosellΓ³, WO 2020/09452S A1. Work also patented, see: WO 2020/09452S A1.